EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Argentine hemorrhagic fever vaccines

Ana Ambrosio, Maria Saavedra, Mauricio Mariani, Graciela Gamboa, Andrea Maiza

Human Vaccines · 2011-06 · 7 (6) · 694-700

DOI: 10.4161/hv.7.6.15198 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Vaccines, online erschienen am 27.10.2014. Verfasst von Ana Ambrosio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Enfermedades Virales Humanas Dr JI Maiztegui, ANLIS, Provincia de Buenos Aires, Argentina. anaambrosio@yahoo.com.ar. Die Arbeit wurde bisher 93-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Argentine hemorrhagic fever (AHF), an acute disease caused by Junin virus (JUNV, Arenaviridae), has been an important issue to public health in Argentina since the early 1950s. The field rodent Calomys musculinus is JUNV natural reservoir and human disease is a consequence of contact with infected rodents. A steady extention of AHF endemic area is being observed since the first reports of the disease. Important achievements have been made in: (a) improvement of methods for the etiological diagnosis; (b) implementation and validation of therapeutical measures; (c) development of vaccines to protect against AHF. Reference is made to different research strategies used to obtain anti-AHF vaccines in the past and anti-arenaviral diseases in the present. Information is updated on features and field performance of Candid #1 vaccine, a live attenuted vaccine currently used to prevent AHF. This vaccine was developed through a joint international effort that envisioned it as an orphan drug. With transferred technology, Argentine government was committed to be Candid #1 manufacturer and to register this vaccine as a novel medical product under the Argentine regulatory authority. Candid #1 vaccine is the first one used to control an arenaviral hemorrhagic fever, the first live viral vaccine to be manufactured and registered in Argentina, reaching its target population through governmental effort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsArenaviruses, New WorldArgentinaHemorrhagic Fever, AmericanHumansRodentiaVaccinationVaccines, AttenuatedViral Vaccines

Substanzen

Vaccines, AttenuatedViral Vaccines

Autor:innen und Institutionen

  • Instituto Nacional de Enfermedades Virales Humanas Dr JI Maiztegui, ANLIS, Provincia de Buenos Aires, Argentina. anaambrosio@yahoo.com.ar

Zitieren

APA

Ambrosio, A., Saavedra, M., Mariani, M., Gamboa, G., & Maiza, A. (2011). Argentine hemorrhagic fever vaccines. Human Vaccines, 7(6), 694-700. https://doi.org/10.4161/hv.7.6.15198

Vancouver

Ambrosio A, Saavedra M, Mariani M, Gamboa G, Maiza A. Argentine hemorrhagic fever vaccines. Human Vaccines. 2011;7(6):694-700. doi:10.4161/hv.7.6.15198

BibTeX
@article{Ambrosio2011,
  author = {Ambrosio, Ana and Saavedra, Maria and Mariani, Mauricio and Gamboa, Graciela and Maiza, Andrea},
  title = {Argentine hemorrhagic fever vaccines},
  journal = {Human Vaccines},
  year = {2011},
  volume = {7},
  number = {6},
  pages = {694--700},
  doi = {10.4161/hv.7.6.15198}
}
Kostenlos starten →